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Abstract
Background: Despite remarkable progress in treatment of chronic heart failure (CHF) over the last two decades, mortality,
personal suffering and cost remain staggering, and effective interventions are still a challenge. Previously we reported that a
blueberry-enriched diet (BD) attenuated necroapoptosis and inflammation in periinfarct area in a rat model of myocardial
infarction (MI).
Objectives: To test the hypothesis that BD will attenuate the course of CHF, including mortality and cardiac remodeling
during the first year after induction of MI in rats.
Method and Results: Two weeks after coronary artery ligation, rats were divided into two groups of similar average MI size,
measured by echocardiography, and then12-mo dietary regimens were initiated as follows: ad libitum regular diet (control,
CD, n=27) and isocaloric food with 2% blueberry supplement (BD, n=27) also available ad libitum. These dietary groups
were compared to each other and to sham group (SH). Mortality over the 12 mo was reduced by 22% in BD compared with
CD (p,0.01). In the course of developing CHF, BD had no effect on the body weight, heart rate or blood pressure. Bi-
monthly Echo revealed significant attenuation of the LV chamber remodeling, LV posterior wall thinning, and MI expansion
in BD compared with CD. In fact, BD arrested the MI expansion.
Conclusion: This is the first experimental evidence that a blueberry-enriched diet has positive effects on the course of CHF
and thus warrants consideration for clinical evaluation.
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Introduction
Chronic heart failure (CHF) is a wide spread, highly disabling
condition usually occurring subsequently to ischemic heart
disease and myocardial infarction, however hypertension,
valvular disease and cardiomyopathy are also contributing
etiologies [1]. In developing countries, an estimated 2–3% of
the adult population and almost 10% of those over 65years of
age suffer from this condition. Moreover, in the age cohort of
70–80 years, the prevalence of CHF reaches 20% [2,3]. For
instance, in 2004, 12.5% of death certificates issued in the US
mentioned CHF [4]. The estimated annual cost of health care
attributed to CHF exceeds $3 5b i l l i o ni nt h eU S ,a n di nt h e
United Kingdom the cost equals 2% of the total budget of the
National Health Service [3,4].
Remarkable progress has been achieved over the last two
decades in treatment of CHF. The use of beta adrenoreceptor
blockers, angiotensin-converting-enzyme inhibitors, aldoste-
rone antagonists, and resychronization therapy revolutionized
the management of CHF [5]. However, despite recognized
successes, the overall annual mortality associated with CHF
remains around 10% [5,6],and qualityof life amongsurvivors is
dramatically reduced as the disease progresses [7,8]. Thus, a
search for new therapeutic interventions to improve the course
of CHF continues.
Reports over the last several years suggested that, at least in
animal experiments, supplementation of the regular diet with
blueberry produces a tissue protective effect: blueberry extract
and blueberry-enriched diets have been shown to attenuate age-
related behavioral and neuronal deficits [9–12], to inhibit
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hippocampal cell loss following experimentally induced stroke
[14]. We have recently reported that myocardial infarct (MI)
size, as well as necroapoptosis and inflammation in peri-infarct
area at 24 hrs after MI induction, are significantly reduced in
rats maintained on blueberry-enriched diet (BD) prior to
induction of MI in comparison with rats on the control diet
(CD) [15]. Our data also suggested that initiation of BD after
MI induction might attenuate left ventricular (LV) remodeling
and MI expansion.
It is generally accepted that a major factor leading to
progression of CHF is cumulative cell loss in myocardium [16].
Since multiple reports suggested that BD possesses tissue-
protective (antiapoptotic and anti-inflammatory) properties, the
objective of this study was to test the effectiveness of 12-mo long
blueberry-enriched diet in the rat model of post MI dilated
cardiomyopathy with mortality as a primary outcome.
Methods
Experimental Design
Male Wistar rats (Charles River Laboratories Inc., Wilmington,
MA), weighing 225–280g, were housed and studied in confor-
mance with the NIH Guide for the Care and Use of Laboratory
Animals, Manual 3040-2 (1999), with institutional Animal Care
and Use Committee approval. Rats were maintained on ad
libitum food (NIH-07 Mouse/Rat diet) with permanent access to
filtered water. The left descending coronary artery was ligated in
86 rats. An additional 10 rats underwent a sham operation (SH)
without actual coronary ligation. Two weeks after surgery, LV
dimensions, ejection fraction (EF) and MI size were measured by
echocardiography (Echo) in surviving coronary ligated and SH
rats. Animals with an MI size greater than 20% but less than 50%
of LV were divided into 2 groups of similar MI size (average and
variability). One MI group, as well as SH (n=10), continued to
receive a regular, control diet (CD, n=27), while for another MI
group the regular diet was replaced with a blueberry-enriched diet
(Harlan Teklad Madison, WI), (BD, n=27), also available ad
libitum as described previously [15]. Briefly, the blueberry
enriched diet was isocoloric with control diet, but contained 2%
of blueberry extract. New dietary regimens started 2 weeks after
coronary ligation and continued for 12 months (4 weeks were
counted as 1 month). Animals were inspected daily for signs of
moribundity by a person blinded to dietary assignments.
Moribund animals were euthanized, and their hearts were
harvested for MI measurements. Daily records of dead or
euthanized animals were used to calculate continuous mortality
curves. Echo was repeated bi-monthly following the initiation of
treatment. Body weight and blood pressure (non-invasive tail-cuff
technique, Coda-6, Kent Scientific, Torrington, CT) were
measured at the same time as Echo. Following the final Echo all
surviving rats were euthanized and their hearts harvested for
histological evaluation.
Coronary Artery Ligation
Rats were anaesthetized with Isoflorene (2% in Oxygen). The
surgical procedure was performed as previously described [17].
Echocardiography
Echocardiography (Sonos 5500, a 12 MHz transducer) was
conducted under light anaesthesia by sodium pentobarbital
(30 mg/kg, i.p.) as previously described [18]. Briefly, parasternal
long axis views were obtained and recorded to ensure that the
mitral and aortic valves and the apex were visualized. Short axis
views were recorded at the mid-papillary muscle level. Endocar-
dial area tracings, using the leading edge method, were performed
in 2D mode (short and long axis views) from digital images
captured on cineloop to calculate end-diastolic and end-systolic
LV areas. End-diastolic volume (EDV) and end-systolic volume
(ESV) were calculated by a modified Simpson’s method. Ejection
fraction (EF) was then derived as EF=(EDV2ESV)/EDV6100.
Left ventricular mass (LVM) was calculated from 2D mode. The
MI size at the mid-papillary muscle level was estimated from 2D
short axis LV images and expressed as a percent of the LV
endocardial circumference. Infarct area was identified as a sharply
demarcated section of the LV free wall that failed to thicken
during systole. The length of the akinetic part of the LV
endocardial circumference was measured from freeze-frame
images at end-diastole. Posterior wall thickness (PWth) was
measured from M-mode. All measurements were made by a
single observer, who was blinded to the identity of the tracings,
and were averaged over three to five consecutive cardiac cycles.
The reproducibility of measurements was assessed in two sets of
baseline measurements in 10 randomly selected rats, and the
repeated measure variability did not exceed 65%.
Histological Acquisition
Histological staining and analyses were performed as previously
described [18]. Briefly, the hearts were isolated and weighed.
Myocardial segments from the mid-papillary muscle level were
imbedded in the paraffin, sectioned (5mm) and stained with
Masson’s trichrome and hematoxylin - eosin staining (H&E). MI
size was expressed as an average percentage of the LV endocardial
and epicardial circumferences that were identified as infarct in the
Masson’s trichrome staining sections.
Statistical Analyses
All data are expressed as mean6SEM. Mortality was reported
via Kaplan-Meier survival analyis. Differences among survival
curves were assessed using Logrank statistical analyses (GraphPad
Prism, 4.02). Reported Echo indices were analyzed using the
repeated measures Linear Mixed-Effects model. Each response
variable was analyzed for main effects of group and time as well as
their interaction. If the group-time interactions were statistically
significantly different among groups, comparisons at different time
point were conducted and their outcome was Bonferroni corrected
for multiple comparison. The model was fit using proc mixed in
SAS 9.1. Power Analysis (PASS 2008 - Repeated Measures
ANOVA) indicated that, for the main effect, a sample size
exceeding 10 animals per group would correspond to a power
above 80%; for the interaction effect, the power for all variables
would be above 70% for samples of 15 or larger. Group
differences in histological data were assessed by Student’s t-test.
Statistical significance was assumed as p,0.05.
Results
Early Mortality Following Coronary Ligation and
Treatment Assignment
Coronary ligation was performed on a total of 86 rats and a
sham operation on 10 rats. During the first 24 hrs after surgery 15
animals died, and 7 more rats died during the first 2 weeks
following surgery. There was no mortality among the 10 sham
operated rats. Two weeks following surgery the 64 rats surviving
coronary ligation and 10 sham operated rats underwent
echocardiography, at which time their pretreatment (baseline)
MI size, LV volumes, and EF were determined. Ten rats, in which
MI size was less than 20% or more than 50% of LV, were
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average MI size of 3161.5% of LV were divided into two dietary
groups (n=27 in each group), that did not differ with respect to
their average baseline echo-derived LV morphometric parameters
(EDV and ESV), EF and MI size. The 10 sham operated rats
served as a control and remained on a regular diet.
Table 1 lists the echo derived pretreatment EDV, ESV and
EF, PWth and MI size for the two experimental groups compared
to the sham group two weeks after surgery. Early, pretreatment,
LV remodeling was similar in both coronary ligated groups and
consisted of substantial increases in EDV (164–171% ) and ESV
(397–430%), and a 57–62% decline of EF compared to SH. The
thickness of posterior wall in coronary ligated rats did not vary
significantly from SH at this time. All measured Echo indices and
MI size were similar between two coronary ligated groups.
Mortality
Figure 1 illustrates the Kaplan-Meier survival curves for the two
groups of experimental animals maintained on different dietary
regimens and the sham operated group during one year following
initiation of treatment. No animals from SH died during the
observation period. In the MI group on control diet (CD) mortality
reached 50% at 6 mo and 81% at 12 mos. The positive effect of
BD treatment on survival became statistically significant by the 7th
month and continued to increase with time so that by the end of
the year the survival among BD improved by 22%, compared to
the CD group (p,0.01, Logrank test).
Body weight and hemodynamics
At the baseline, i.e., 2 weeks after surgery, mean body weight
was slightly lower in MI animals (BD and CD) than in SH
(Fig. 2A). However, starting at the second month, the body weight
was similar among all three groups. The BD did not affect the rate
of body growth. Heart rate (Fig. 2B) steadily declined as animals
became older and bigger, however there were no differences
among groups, i.e., neither surgery, nor the diet, affected the
age-related reduction in heart rate. Results of non-invasive
measurements of blood pressure are presented in Figure 2C.
Systolic and diastolic blood pressures did not differ between diet
groups and both diet groups did not differ from SH.
Infarct Expansion
Figure 3 illustrates the MI expansion during 12 months of
treatment. Fig. 3A presents data for all animals, while Fig. 3B
illustrates the results obtained only from the rats that survived until
the end of the study. In both panels A and B the MI expansion was
assessed bi-monthly from Echo measurements and expressed as
the percent of LV perimeter. Figure 3C illustrates the MI size,
assessed from histological preparations at the termination of the
study, or at the time of death. Echo derived and histological
measurements were highly correlated (R
2=0.7). In CD rats the
average MI expanded from 30.161.3% of LV 2 weeks after
coronary ligation to 46.261.7% of LV at the end of 12 months,
i.e., during the 12 months of observation the MI expanded by
50%. MI expansion was attenuated in BD (p,0.001 vs CD). In
fact, the average MI size in BD never exceeded the baseline level,
and was significantly smaller than in CD at all time points except
baseline, at which time the MI was similar between groups. MI
size measured histologically in rats that survived 12 month after
coronary ligation also indicated a significant attenuation of MI
expansion in BD (35% of LV vs 45% in CD, p,0.01).
LV Remodeling and Function
Figure 4 illustrates the progression of LV remodeling (EDV and
ESV expansion) and functional decline (EF reduction) during the
experimental period. Upper panels represent average measure-
ments from all animals at each time point, while lower panels
represent only animals that survived to the end of the study. In CD
animals the LV volume monotonically increased by 90% and
120% for EDV and ESV respectively, while EF declined by 50%.
At the end of the observation period EDV in CD animals averaged
1170675 mL, ESV was 1028683 mL, and EF was 12.561.8%.
For comparison (data not shown) the LV EDV in SH animals at
the end of observation was only 506613 mL, ESV was
242610 mL, and EF was 5261.9%. The expansion of LV
volumes was significantly attenuated in BD compared to CD
when all animals (upper panels) were compared (group6time
interaction derived from repeated measures ANOVA was p,0.05
and p,0.01 for EDV and ESV respectively). The differences
between diet groups became noticeable starting around 6 months.
However, the LV expansion was similar in both diet groups when
only survivors were compared (lower panels). During the 12
months of the study the decline in EF was not significantly
attenuated in BD, compared to CD, with exception of slight
improvement in BD at the middle of observation period.
Echo calculated LVM (Figure 5A) increased in both MI groups
compared to SH, and was not affected by diet. On the other hand,
posterior wall thickness (Figure 5B) became significantly reduced
Table 1. Echo derived pre-diet indices of LV remodeling and MI
size at 2 weeks following coronary ligation or sham operation.
SH CD BD
EDV (mL) 227666 1 6 614*** 606619***
ESV (mL) 90654 6 6 617*** 464622***
PWth (mm) 1.5160.04 1.4560.06 1.3560.05
EF(%) 60.761.8 24.961.4*** 22.561.4***
MI(%) NA 30.161.3 3161.5
*** - p,0.001 vs SH.
doi:10.1371/journal.pone.0007975.t001
Figure 1. 12-mo survival after MI. Kaplan-Meier survival curves
following induction of MI in a sham operated group (SH- n=10), and
two groups with MI maintained on control diet (CD - n=27) or
blueberry-enriched diet (BD - n=27).
doi:10.1371/journal.pone.0007975.g001
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PLoS ONE | www.plosone.org 3 November 2009 | Volume 4 | Issue 11 | e7975Figure 2. Effect of blueberry-enriched diet on basic physiological parameters. Body weight (A), heart rate (B), and arterial blood pressure
(C). Note, results of blood pressure measurements are not available for the first 2 time points.
doi:10.1371/journal.pone.0007975.g002
Figure 3. Effect of blueberry-enriched diet on MI expansion. MI expansion was measured by echocardiography (A, B) and histologically (C) in
all animals and in animals that survived 12 months following induction of MI.
doi:10.1371/journal.pone.0007975.g003
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PLoS ONE | www.plosone.org 4 November 2009 | Volume 4 | Issue 11 | e7975Figure 4. Effect of blueberry-enriched diet on cardiac remodeling. LV end-diastolic volume (left panels), end-systolic volume (middle
panels), and ejection fraction (right panels) estimated by bi-monthly Echo during 12 months following induction of MI in rats maintained on
control or blueberry-enriched diets. Upper panels - all animals. Lower panels - only animals that survived 12 months following induction
of MI.
doi:10.1371/journal.pone.0007975.g004
Figure 5. Effect of blueberry-enriched diet on cardiac remodeling. LV mass (A) and posterior wall thickness (B) estimated by bi-monthly Echo
during 12 months following induction of MI in rats maintained on control or blueberry-enriched diets and in sham operated rats.
doi:10.1371/journal.pone.0007975.g005
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did not differ from SH in MI animals fed the BD.
Discussion
In our previous study we have demonstrated for the first time
that a natural product such as blueberry, supplemented to a
regular diet so that to constitute about 2% of daily food intake,
protected the myocardium of rats from ischemic damage
induced by ligation of a coronary artery via reducing necro-
apoptosis in periinfarct area and ultimately reducing the size of
developing myocardial infarct. We have also demonstrated that
isolated cardiomyocytes from rats maintained on the blueberry-
enriched diet have increased mitochondrial permeability
threshold - a finding that provides an apparent mechanistic
basis for developed cardioprotection. The present study
extended previous findings and proved in a one-year long
experiment on rats that BD, initiated two weeks after induced
myocardial infarction, attenuated LV remodeling and MI
expansion, prevented the progressive thinning of LV wall, and
actually reduced by 22% the mortality associated with
developing chronic heart failure.
It is generally accepted now that chronic heart failure is
accompanied by low, but persistent, level of cordiomyocyte death
[19]. It had been shown that at any given time approximately
0.25% of myocytes undergo an apoptotic transformation in the
failing human heart. This rate of apoptosis is 100-fold more than
in normal heart and more than enough to ensure the progression
of failure. For instance it was shown in a mouse model that even a
very small increase of the rate of cardiomyocyte loss (0.023%
compared to a normal rate of 0.002%) is sufficient to cause a
development over time of lethal dilated cardiomyopathy [20]. The
rate of cardiamyocyte necrosis is also elevated in the failing human
heart to a degree exceeding the rate of apoptosis [21]. Increased
rate of apoptosis and necrosis in the failing heart presents a
valuable therapeutic target, and benefit of pharmacologically
suppressed apoptosis had been demonstrated in experimental
models [22].
It is reasonable to assume that an antiapoptotic effect of the
blueberry-enriched diet that we demonstrated in the acute stage of
experimental myocardial infarction [15] is responsible for
amelioration of cardiac remodeling and MI expansion, and
ultimately reduced mortality in developing post-MI chronic heart
failure as we observed in the present study. It is certain that
increased mitochondrial permeability threshold associated with
prolonged blueberry-enriched diet in rats [15] plays an important
role in cardiac protection in the present, post-MI dilated
cardiomyopathy model. As to the exact nature of increased
mitochondrial permeability threshold, the possibilities are too
numerous, such that their identification, while important and
possible, is out of scope of the present work. For instance, the
antioxidant properties of blueberries are well known [23] and
ROS scavenging mechanisms were identified as one of the
mechanisms involved in the increase of mitochondrial permeabil-
ity threshold [24]. On the other hand there are numerous and not
necessarily antioxidant mechanisms which could be involved. For
example, a large number of kinase-signaling cascades had been
shown to be involved in regulation of the mitochondrial
permeability threshold, for instance PKA, PKB/Akt, p70S6K,
PKC, PKG, and GSK-3b [25].
In summary, we present the first experimental evidence that in a
rat model of post myocardial infarction dilated cardiomyopathy, a
blueberry-enriched diet improved one-year survival, attenuated
LV remodeling, prevented LV wall thinning, and arrested MI
expansion.
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